Daniel's References 1. Sola, S., Tarancón, T., Peña-Casanova, J., Espadaler, J., Langohr, K., Poudevida, S., & ... Torre, R. (2008). Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: evidence from a 12-month longitudinal study. Psychopharmacology, 200(3), 425-437. doi:10.1007/s00213-008-1217-5 (4*)
2. Rivas-Vazquez, R. A., & Delgado, L. (2002). Clinical and Toxic Effects of MDMA ('Ecstacy'). Professional Psychology: Research & Practice, 33(4), 422.
McGraw-Hill Ryerson. 2012. Drugs, Behaviour, and Society. Retrieved November 25, 2013.
Jazmine's References__
1. Halpern, J. H., Sherwood, A. R., Hudson, J. I., et al. Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs. Addiction 2011;106: 777-86. Retrieved: November 20, 2013
2. Substance Abuse and Mental Health Services Administration, Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-41, HHS Publication No. (SMA) 11-4658. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2011. http://www.drugs.com/mdma.html Retrieved: November 20, 2013
http://greenestone.net/treatment/treatment-program/ Retrieved: n.d 2013
Kyles references
1 - Freeman, Shanna. "Top 10 Myths About the Brain" 17 September 2008. HowStuffWorks.com. <http://science.howstuffworks.com/life/inside-the-mind/human-brain/10-brain-myths.htm> 14 November 2013.
2 - Concar, D. (2002, November 6). Ecstasy has dramatic effect on Parkinson's symptoms. - 06 November 2002. Retrieved November 21, 2013, from http://www.newscientist.com/article/dn3015-ecstasy-has-dramatic-effect-on-parkinsons-symptoms.html#.Uo5KBtI_uFt
3 - N.A, A. (2007, June 1). Ecstasy drains spinal fluid?. Go Ask Alice!. Retrieved November 21, 2013, from http://goaskalice.columbia.edu/ecstasy-drains-spinal-fluid
Daniel's References
1. Sola, S., Tarancón, T., Peña-Casanova, J., Espadaler, J., Langohr, K., Poudevida, S., & ... Torre, R. (2008). Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: evidence from a 12-month longitudinal study. Psychopharmacology, 200(3), 425-437. doi:10.1007/s00213-008-1217-5 (4*)
2. Rivas-Vazquez, R. A., & Delgado, L. (2002). Clinical and Toxic Effects of MDMA ('Ecstacy'). Professional Psychology: Research & Practice, 33(4), 422.
Kristen's References
"In the beginning" November 13 2013. <http://thedea.org/druglinks.html>
McGraw-Hill Ryerson. 2012. Drugs, Behaviour, and Society. Retrieved November 25, 2013.
Jazmine's References__
1. Halpern, J. H., Sherwood, A. R., Hudson, J. I., et al. Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs. Addiction 2011;106: 777-86. Retrieved: November 20, 2013
2. Substance Abuse and Mental Health Services Administration, Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-41, HHS Publication No. (SMA) 11-4658. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2011.
http://www.drugs.com/mdma.html Retrieved: November 20, 2013
3. No author, (2011) "Ecstasy", Brown University-Health Education http://brown.edu/Student_Services/Health_Services/Health_Education/alcohol,_tobacco,_&_other_drugs/ecstasy.php Retrieved: November 20, 2013
4. National Institute of Drug Abuse, (2011), "What are the affects of MDMA", About.com/health.
http://alcoholism.about.com/cs/ecstasy/f/mdma_faq04.htm Retrieved: November 20, 2013